Editorial: Multifaceted Cannabinoids: Regulators of Normal and Pathological Function in Metabolic and Endocrine Organs.
作者信息
Szanda Gergő, Mariscal Isabel Gonzalez, Jourdan Tony
机构信息
Department of Physiology, Faculty of Medicine, Semmelweis University, Budapest, Hungary.
Instituto de Investigaciones Biomédicas de Málaga, Universidad de Málaga, Málaga, Spain.
出版信息
Front Endocrinol (Lausanne). 2022 Feb 7;13:848050. doi: 10.3389/fendo.2022.848050. eCollection 2022.
Abstract
摘要
相似文献
1
Editorial: Multifaceted Cannabinoids: Regulators of Normal and Pathological Function in Metabolic and Endocrine Organs.社论：多面性大麻素：代谢和内分泌器官正常及病理功能的调节因子
Front Endocrinol (Lausanne). 2022 Feb 7;13:848050. doi: 10.3389/fendo.2022.848050. eCollection 2022.
2
The endocannabinoid receptors CB1 and CB2 affect the regenerative potential of adipose tissue MSCs.内源性大麻素受体 CB1 和 CB2 影响脂肪组织间充质干细胞的再生潜能。
Exp Cell Res. 2020 Apr 1;389(1):111881. doi: 10.1016/j.yexcr.2020.111881. Epub 2020 Jan 29.
3
Receptor-heteromer mediated regulation of endocannabinoid signaling in activated microglia. Role of CB and CB receptors and relevance for Alzheimer's disease and levodopa-induced dyskinesia.激活小胶质细胞中内源性大麻素信号的受体异源三聚体调节。CB 和 CB 受体的作用及其与阿尔茨海默病和左旋多巴诱导运动障碍的相关性。
Brain Behav Immun. 2018 Jan;67:139-151. doi: 10.1016/j.bbi.2017.08.015. Epub 2017 Aug 24.
4
Hepatic expression of cannabinoid receptors CB1 and CB2 correlate with fibrogenesis in patients with chronic hepatitis B.慢性乙型肝炎患者肝组织中大麻素受体 CB1 和 CB2 的表达与肝纤维化相关。
Int J Infect Dis. 2017 Jun;59:124-130. doi: 10.1016/j.ijid.2017.03.008. Epub 2017 Mar 15.
5
The effects of cannabinoids on the endocrine system.大麻素对内分泌系统的影响。
Endokrynol Pol. 2018;69(6):705-719. doi: 10.5603/EP.a2018.0072.
6
Non-CB1, non-CB2 receptors for endocannabinoids, plant cannabinoids, and synthetic cannabimimetics: focus on G-protein-coupled receptors and transient receptor potential channels.内源性大麻素、植物大麻素和合成大麻类似物的非 CB1、非 CB2 受体：重点是 G 蛋白偶联受体和瞬时受体电位通道。
J Neuroimmune Pharmacol. 2010 Mar;5(1):103-21. doi: 10.1007/s11481-009-9177-z. Epub 2009 Oct 22.
7
Inactivation of fatty acid amide hydrolase exacerbates experimental fibrosis by enhanced endocannabinoid-mediated activation of CB1.脂肪酸酰胺水解酶失活通过增强内源性大麻素介导的 CB1 激活加剧实验性纤维化。
Ann Rheum Dis. 2012 Dec;71(12):2051-4. doi: 10.1136/annrheumdis-2012-201823. Epub 2012 Aug 22.
8
Differential expression of cannabinoid receptors in the human colon: cannabinoids promote epithelial wound healing.大麻素受体在人结肠中的差异表达：大麻素促进上皮伤口愈合。
Gastroenterology. 2005 Aug;129(2):437-53. doi: 10.1016/j.gastro.2005.05.026.
9
[The endocannabinoid system as a novel target for the treatment of liver fibrosis].[内源性大麻素系统作为治疗肝纤维化的新靶点]
Pathol Biol (Paris). 2008 Feb;56(1):36-8. doi: 10.1016/j.patbio.2007.01.001. Epub 2007 Apr 6.
10
Pharmacological data of cannabidiol- and cannabigerol-type phytocannabinoids acting on cannabinoid CB, CB and CB/CB heteromer receptors.大麻素 CB、CB 和 CB/CB 杂二聚体受体作用的大麻二酚和大麻萜酚型植物大麻素的药理学数据。
Pharmacol Res. 2020 Sep;159:104940. doi: 10.1016/j.phrs.2020.104940. Epub 2020 May 26.
本文引用的文献
1
The therapeutic potential of second and third generation CBR antagonists.第二代和第三代 CBR 拮抗剂的治疗潜力。
Pharmacol Ther. 2020 Apr;208:107477. doi: 10.1016/j.pharmthera.2020.107477. Epub 2020 Jan 9.
Zotero 插件